クリグルファーマ株式会社

news

Mar 2, 2020Notice

Kringle Pharma successfully raises 950 million Japanese yen to advance clinical development of recombinant human HGF.

PDF
Mar 2, 2020Notice

Kringle Pharma and Toho Holdings enter into a capital and business alliance for KP-100IT in acute spinal cord injury.

PDF